title: Drug therapy: Preclinical oncology - reporting transparency needed.
authors.affiliation: Thoracic Oncology Section, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
authors.forename: Eric E
authors.initials: EE
authors.lastname: Gardner
authors.affiliation: Drukenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, New York 10065, USA.
authors.forename: Charles M
authors.initials: CM
authors.lastname: Rudin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008495:Medical Oncology; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011758:Pyrroles / Q000627:therapeutic use*; D012107:Research Design; D058028:Research Report / Q000592:standards*; D013274:Stomach Neoplasms / Q000188:drug therapy; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib